-
, computational biology and clinical neurology and collaborate with POLARIS partners across Europe. Through planned secondments, you will gain experience in omics research, biomarker development and patient
-
cell-based disease modelling, neuroscience and translational research. Through planned secondments, you will also gain experience with MLC animal models and computational chemistry approaches
-
institutions and several industrial partners with extensive expertise in quantitative imaging, image analysis and imaging technology. By conducting research in both academic and industrial settings, PhD
-
Vrije Universiteit Brussel (VUB) is the recruiting organisation for this position. You will be employed by the Molecular Imaging and Therapy (MITH) research group and embedded in the POLARIS consortium. Your academic supervision will be provided by Prof. Timo De Groof and Prof. Nick...
-
their impact on patient care. You have: an MSc degree in biomedical engineering, applied mathematics, computer science, physics or a related discipline; demonstrable experience with scientific programming
-
4 Sep 2026 Job Information Organisation/Company Amsterdam UMC Research Field Medical sciences » Medicine Psychological sciences » Psychology Researcher Profile First Stage Researcher (R1
-
Deadline 5 Oct 2026 - 21:59 (UTC) Country Netherlands Type of Contract Temporary Job Status Not Applicable Hours Per Week 36.0 Is the job funded through the EU Research Framework Programme? Not funded by a
-
, disease monitoring and treatment evaluation. You will work closely with researchers in human genetics, computational biology and clinical neurology and collaborate with POLARIS partners across Europe
-
institutions and several industrial partners with extensive expertise in quantitative imaging, image analysis and imaging technology. By conducting research in both academic and industrial settings, PhD
-
patient-informed treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical